Structural preferences among folate compounds and their analogues for ATPase-mediated efflux by inside-out plasma membrane vesicles derived from L1210 cells-Reference-Cited by-同舟云学术

Structural preferences among folate compounds and their analogues for ATPase-mediated efflux by inside-out plasma membrane vesicles derived from L1210 cells

Published:1995-05 Issue:10 Volume:49 Page:1427-1433
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Schlemmer Scott R.,Sirotnak Francis M.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference23 articles.

1. Antifolate transport in L1210 leukemia cells. Kinetic evidence for the nonidentity of carriers for influx and efflux;Dembo;Biochim Biophys Acta,1976

2. Effects of metabolic deprivation on methotrexate transport in L1210 leukemia cells: Further evidence for separate influx and efflux systems with different energetic requirements;Dembo;J Membr Biol,1984

3. The characteristic of membrane transport of amethopterin and the natural occurring folates;Goldman;Ann NY Acad Sci,1971

4. Correlates of folate analog transport, pharmacokinetics and selective antitumor action;Sirotnak;Pharmacol Ther,1980

5. Obligate genetic expression in tumor cells of a fetal membrane property mediating “folate” transport: Biological significance and implications for improved therapy of human cancer;Sirotnak;Cancer Res,1985

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance;Drug Resistance Updates;2012-08

2. Metal complexes with the ligand derived from 6-acetyl-1,3,7-trimethyllumazine and benzohydrazide. Molecular structures of two new Co(II) and Rh(III) complexes and analysis of in vitro antitumor activity;Journal of Inorganic Biochemistry;2008-08

3. Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells;Leukemia & Lymphoma;2008-01

4. Resistance to antifolates;Oncogene;2003-10

5. Efficient utilization of the reduced folate carrier in CCRF-CEM human leukemic lymphoblasts by the potent antifolate Nα-(4-amino-4-deoxypteroyl)-Nδ-hemiphthaloyl-l-ornithine (PT523) and its B-ring analogues;Biochemical Pharmacology;2000-07